Innovator CEO Profile. In this Innovation Lab interview series, Smythe discusses SomaLogic’s origin story, the potential of proteomics for precision health, what’s next for the company and more.
Impact Report CEO takeaways
• Challenge current CVD diagnostics and treatment and understand the power of proteomics in diagnosing and treating CVD.
• Improve patient CVD management through risk stratification using a protein-based blood test.
• Detect CVD risk that is not identified by traditional risk assessment tools.
• Drive patient attitudes and behavior through individualized risk assessment.